Skip to content
10-K

Annual Report

MIRA PHARMACEUTICALS, INC. MIRA

0001493152-26-014001

← back to feed
Filed
Mar 31, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 30, 2026 42.02M sh
Operating Cash Flow FY 2025 · Dec 31, 2025 −$4.66M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$5.56M
Short Term Investments FY 2025 · Dec 31, 2025 $4.68M
Cash And Equivalents FY 2025 · Dec 31, 2025 $6.35M
Cash And Equivalents FY 2025 · Dec 31, 2024 $2.83M
Stockholders Equity FY 2025 · Dec 31, 2025 $10.39M
Stockholders Equity FY 2025 · Dec 31, 2024 $2.2M
Stockholders Equity FY 2025 · Dec 31, 2023 $4.37M
Current Liabilities FY 2025 · Dec 31, 2025 $702.07K
Current Liabilities FY 2025 · Dec 31, 2024 $723.35K
Total Liabilities FY 2025 · Dec 31, 2025 $702.07K
Total Liabilities FY 2025 · Dec 31, 2024 $723.35K
Current Assets FY 2025 · Dec 31, 2025 $11.06M
Current Assets FY 2025 · Dec 31, 2024 $2.89M
Total Assets FY 2025 · Dec 31, 2025 $11.09M
Total Assets FY 2025 · Dec 31, 2024 $2.92M
Eps Diluted FY 2025 · Dec 31, 2025 −$1.35
Eps Diluted FY 2025 · Dec 31, 2024 −$0.51
Eps Basic FY 2025 · Dec 31, 2025 −$1.35
Eps Basic FY 2025 · Dec 31, 2024 −$0.51
Sga Expense FY 2025 · Dec 31, 2025 $8.77M
Sga Expense FY 2025 · Dec 31, 2024 $4.71M
Rd Expense FY 2025 · Dec 31, 2025 $1.72M
Rd Expense FY 2025 · Dec 31, 2024 $3.31M
Net Income FY 2025 · Dec 31, 2025 −$10.44M
Net Income FY 2025 · Dec 31, 2024 −$7.85M